Amy V Watson, MD
Family Practice · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Indian Health Center of Santa Clara Valley · 37 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Watson’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A104098 · Current
Licensed to practise in California · since 2008 · expires 2028-01-31 · Medical College of Georgia.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$210
Medicare paid this office $210 for 18 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
18 Original Medicare patients in 2024. Average age 75 · Health risk score 1.78. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 75%.
The office billed $392, Medicare allowed $235 and paid $210; for 23 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 18 | 23 | 75 | 1.78 | $392 | $210 |
| 2023 | 17 | 22 | 77 | 1.21 | $647 | $461 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
Medicaid work
$238,010 in 2024
Medicaid paid $238,010 for 2,400 billed services this clinician did in 2024, up to 95 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 902 | $228,063 |
| Return visit (30+ min) | 793 | $5,487 |
| Short return visit (20+ min) | 634 | $4,082 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 34 | $371 |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use | 19 | $4 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, single dose | 18 | $3 |
| 2024 | 2,400 | 6 | 95 | $238,010 |
| 2023 | 2,642 | 5 | 125 | $238,296 |
| 2022 | 2,189 | 5 | 115 | $195,448 |
| 2021 | 3,175 | 6 | 142 | $321,717 |
| 2020 | 2,635 | 6 | 141 | $263,810 |
| 2019 | 2,525 | 8 | 115 | $266,242 |
| 2018 | 1,850 | 5 | 140 | $287,054 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 978 | $234,061 |
| Return visit (30+ min) | 778 | $2,080 |
| Short return visit (20+ min) | 832 | $1,682 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 41 | $470 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, single dose | 13 | $5 |
2022
| Clinic visit/encounter, all-inclusive | 835 | $192,435 |
| Short return visit (20+ min) | 872 | $2,009 |
| Return visit (30+ min) | 410 | $918 |
| Short return visit | 40 | $86 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 32 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 1,355 | $317,857 |
| Short return visit (20+ min) | 1,408 | $3,038 |
| Short return visit | 257 | $438 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 60 | $384 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 81 | $0 |
| Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | 14 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 1,143 | $261,135 |
| Short return visit (20+ min) | 1,094 | $2,292 |
| Short return visit | 218 | $383 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion | 53 | $0 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 86 | $0 |
| Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | 41 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 1,161 | $262,453 |
| Short return visit (20+ min) | 953 | $2,469 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 44 | $520 |
| Short return visit | 124 | $316 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 50 | $309 |
| Return visit (30+ min) | 72 | $171 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 15 | $3 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 106 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 1,159 | $257,991 |
| Short return visit (20+ min) | 621 | $28,430 |
| Return visit (30+ min) | 43 | $347 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 12 | $220 |
| Short return visit | 15 | $66 |
Drugs they prescribed that Part D paid
$169,550
Pharmacies billed $169,550 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 7% of their Part D prescriptions (102 of 1,551) in 2024. A higher opioid share than 9 in 10 peers; the typical family practice clinician is at 2%.
1,291 generic and 247 brand-name prescriptions · $169,550 in drug cost · 17 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 34 | $31,352 | $922 |
| Eliquis | 21 | $22,657 | $1,079 |
| Jardiance | 16 | $22,164 | $1,385 |
| Basaglar Kwikpen U-100 | 11 | $6,062 | $551 |
| Breo Ellipta | 12 | $5,642 | $470 |
See all 41 drugs
| Ozempic | 34 | $31,352 | $922 |
| Eliquis | 21 | $22,657 | $1,079 |
| Jardiance | 16 | $22,164 | $1,385 |
| Basaglar Kwikpen U-100 | 11 | $6,062 | $551 |
| Breo Ellipta | 12 | $5,642 | $470 |
| Atrovent Hfa | 11 | $4,859 | $442 |
| Buprenorphine-Naloxone | 14 | $2,216 | $158 |
| Albuterol Sulfate Hfa | 47 | $1,658 | $35 |
| Hydrocodone-Acetaminophen | 91 | $1,099 | $12 |
| Diclofenac | 37 | $1,053 | $28 |
| Atorvastatin | 134 | $697 | $5 |
| Levothyroxine | 40 | $685 | $17 |
| Tamsulosin | 33 | $586 | $18 |
| Metoprolol | 38 | $529 | $14 |
| Gabapentin | 27 | $498 | $18 |
| Digoxin | 12 | $422 | $35 |
| Losartan | 58 | $384 | $7 |
| Pantoprazole | 33 | $365 | $11 |
| Duloxetine | 15 | $316 | $21 |
| Primidone | 12 | $265 | $22 |
| Rosuvastatin | 11 | $257 | $23 |
| Omeprazole | 24 | $253 | $11 |
| Fluticasone Propionate | 21 | $248 | $12 |
| Metformin | 38 | $240 | $6 |
| Pravastatin | 11 | $223 | $20 |
| Cyclobenzaprine | 25 | $203 | $8 |
| Glipizide | 31 | $191 | $6 |
| Amlodipine Besylate | 46 | $166 | $4 |
| Trazodone | 18 | $162 | $9 |
| Ibuprofen | 19 | $152 | $8 |
| Oxycodone-Acetaminophen | 11 | $139 | $13 |
| Famotidine | 12 | $124 | $10 |
| Lisinopril | 40 | $123 | $3 |
| Sumatriptan | 14 | $113 | $8 |
| Alendronate | 22 | $112 | $5 |
| Naproxen | 15 | $106 | $7 |
| Fluoxetine | 14 | $82 | $6 |
| Furosemide | 13 | $65 | $5 |
| Sertraline | 14 | $60 | $4 |
| Hydrochlorothiazide | 19 | $58 | $3 |
| Simvastatin | 23 | $52 | $2 |
Year by year
| 2024 | 1,551 | 101 | 7% (102) | 16% | $169,550 |
| 2023 | 1,555 | 112 | 7% (111) | 14% | $197,405 |
| 2022 | 1,536 | 117 | 6% (98) | 12% | $185,329 |
| 2021 | 1,680 | 117 | 7% (115) | 13% | $185,588 |
| 2020 | 1,762 | 116 | 8% (135) | 11% | $113,161 |
| 2019 | 1,695 | 124 | 9% (148) | 13% | $111,645 |
| 2018 | 1,230 | 112 | 10% (120) | None | $75,523 |
| 2017 | 15 | 11 | None | None | $722 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 40 drugs
| Ozempic | 31 | $36,403 | $1,174 |
| Jardiance | 15 | $21,131 | $1,409 |
| Eliquis | 20 | $17,216 | $861 |
| Basaglar Kwikpen U-100 | 12 | $6,690 | $557 |
| Advair Diskus | 12 | $5,877 | $490 |
| Atorvastatin | 148 | $3,260 | $22 |
| Diclofenac | 40 | $2,938 | $73 |
| Buprenorphine-Naloxone | 13 | $2,698 | $208 |
| Hydrocodone-Acetaminophen | 96 | $1,655 | $17 |
| Albuterol Sulfate Hfa | 36 | $1,477 | $41 |
| Losartan | 42 | $1,416 | $34 |
| Tamsulosin | 33 | $1,335 | $40 |
| Levothyroxine | 41 | $1,084 | $26 |
| Gabapentin | 26 | $1,055 | $41 |
| Ventolin Hfa | 16 | $990 | $62 |
| Fluticasone Propionate | 38 | $905 | $24 |
| Amlodipine Besylate | 53 | $825 | $16 |
| Metoprolol | 44 | $731 | $17 |
| Lisinopril | 62 | $729 | $12 |
| Duloxetine | 16 | $673 | $42 |
| Digoxin | 12 | $543 | $45 |
| Simvastatin | 21 | $521 | $25 |
| Glipizide | 25 | $456 | $18 |
| Fenofibrate | 12 | $427 | $36 |
| Trazodone | 26 | $393 | $15 |
| Omeprazole | 22 | $390 | $18 |
| Pantoprazole | 17 | $359 | $21 |
| Fluoxetine | 16 | $344 | $21 |
| Alendronate | 17 | $327 | $19 |
| Famotidine | 17 | $316 | $19 |
| Metformin | 25 | $303 | $12 |
| Benazepril | 18 | $268 | $15 |
| Clopidogrel | 14 | $258 | $18 |
| Hydrochlorothiazide | 18 | $172 | $10 |
| Oxycodone-Acetaminophen | 14 | $128 | $9 |
| Primidone | 12 | $123 | $10 |
| Ibuprofen | 12 | $97 | $8 |
| Sumatriptan | 11 | $89 | $8 |
| Furosemide | 15 | $89 | $6 |
| Diazepam | 11 | $45 | $4 |
2022: 40 drugs
| Trulicity | 11 | $29,856 | $2,714 |
| Jardiance | 14 | $18,474 | $1,320 |
| Eliquis | 19 | $16,239 | $855 |
| Lantus Solostar | 22 | $16,215 | $737 |
| Advair Diskus | 13 | $6,760 | $520 |
| Buprenorphine-Naloxone | 16 | $3,052 | $191 |
| Atorvastatin | 154 | $2,392 | $16 |
| Albuterol Sulfate Hfa | 32 | $1,825 | $57 |
| Hydrocodone-Acetaminophen | 86 | $1,663 | $19 |
| Gabapentin | 49 | $1,648 | $34 |
| Diclofenac | 22 | $1,316 | $60 |
| Levothyroxine | 43 | $1,017 | $24 |
| Losartan | 42 | $872 | $21 |
| Fluticasone Propionate | 52 | $713 | $14 |
| Metoprolol | 53 | $632 | $12 |
| Digoxin | 13 | $589 | $45 |
| Lisinopril | 89 | $579 | $7 |
| Trazodone | 33 | $510 | $15 |
| Omeprazole | 25 | $414 | $17 |
| Amlodipine Besylate | 53 | $396 | $7 |
| Tamsulosin | 27 | $379 | $14 |
| Benazepril | 26 | $299 | $11 |
| Glipizide | 35 | $298 | $9 |
| Clindamycin Phosphate | 11 | $294 | $27 |
| Promethazine | 11 | $282 | $26 |
| Naproxen | 23 | $231 | $10 |
| Pantoprazole | 16 | $212 | $13 |
| Citalopram Hbr | 11 | $212 | $19 |
| Fenofibrate | 12 | $212 | $18 |
| Metformin | 18 | $192 | $11 |
| Clopidogrel | 14 | $188 | $13 |
| Famotidine | 13 | $141 | $11 |
| Furosemide | 13 | $123 | $9 |
| Ibuprofen | 15 | $122 | $8 |
| Primidone | 13 | $108 | $8 |
| Hydrochlorothiazide | 17 | $104 | $6 |
| Allopurinol | 12 | $103 | $9 |
| Alendronate | 13 | $99 | $8 |
| Simvastatin | 13 | $89 | $7 |
| Diazepam | 11 | $55 | $5 |
2021: 44 drugs
| Jardiance | 18 | $25,041 | $1,391 |
| Januvia | 11 | $15,801 | $1,436 |
| Eliquis | 19 | $15,557 | $819 |
| Lantus Solostar | 14 | $15,383 | $1,099 |
| Toujeo Solostar | 13 | $4,914 | $378 |
| Buprenorphine-Naloxone | 19 | $2,644 | $139 |
| Albuterol Sulfate Hfa | 44 | $2,554 | $58 |
| Atorvastatin | 145 | $2,251 | $16 |
| Hydrocodone-Acetaminophen | 102 | $2,033 | $20 |
| Diclofenac | 31 | $1,833 | $59 |
| Levothyroxine | 56 | $1,421 | $25 |
| Ondansetron | 13 | $1,119 | $86 |
| Gabapentin | 46 | $1,106 | $24 |
| Fluticasone Propionate | 59 | $886 | $15 |
| Tamsulosin | 41 | $824 | $20 |
| Metoprolol | 45 | $823 | $18 |
| Baclofen | 14 | $820 | $59 |
| Ultra-Fine Short Pen Needle | 14 | $809 | $58 |
| Lisinopril | 96 | $724 | $8 |
| Losartan | 38 | $716 | $19 |
| Rosuvastatin | 11 | $568 | $52 |
| Amlodipine Besylate | 64 | $529 | $8 |
| Duloxetine | 11 | $501 | $46 |
| Metformin | 35 | $382 | $11 |
| Simvastatin | 27 | $319 | $12 |
| Omeprazole | 25 | $318 | $13 |
| Trazodone | 23 | $266 | $12 |
| Pravastatin | 13 | $262 | $20 |
| Glipizide | 38 | $239 | $6 |
| Famotidine | 13 | $238 | $18 |
| Quetiapine | 13 | $230 | $18 |
| Citalopram Hbr | 17 | $193 | $11 |
| Fenofibrate | 12 | $185 | $15 |
| Naproxen | 18 | $184 | $10 |
| Benazepril | 25 | $168 | $7 |
| Clopidogrel | 13 | $142 | $11 |
| Alendronate | 18 | $132 | $7 |
| Atenolol | 11 | $125 | $11 |
| Primidone | 11 | $119 | $11 |
| Oxycodone-Acetaminophen | 12 | $109 | $9 |
| Hydrochlorothiazide | 21 | $105 | $5 |
| Zolpidem | 12 | $86 | $7 |
| Allopurinol | 11 | $80 | $7 |
| Diazepam | 13 | $48 | $4 |
2020: 42 drugs
| Lantus Solostar | 12 | $13,736 | $1,145 |
| Diclofenac | 41 | $3,104 | $76 |
| Ventolin Hfa | 22 | $3,024 | $137 |
| Hydrocodone-Acetaminophen | 103 | $1,946 | $19 |
| Atorvastatin | 137 | $1,822 | $13 |
| Fluticasone Propionate | 54 | $1,417 | $26 |
| Levothyroxine | 52 | $1,325 | $25 |
| Gabapentin | 42 | $1,232 | $29 |
| Albuterol Sulfate Hfa | 21 | $911 | $43 |
| Tamsulosin | 41 | $790 | $19 |
| Ultra-Fine Short Pen Needle | 14 | $773 | $55 |
| Metoprolol | 46 | $727 | $16 |
| Duloxetine | 24 | $624 | $26 |
| Baclofen | 21 | $609 | $29 |
| Oxycodone-Acetaminophen | 11 | $524 | $48 |
| Amlodipine Besylate | 69 | $478 | $7 |
| Lisinopril | 69 | $409 | $6 |
| Amitriptyline | 19 | $400 | $21 |
| Losartan | 35 | $391 | $11 |
| Naproxen | 31 | $313 | $10 |
| Pravastatin | 18 | $294 | $16 |
| Quetiapine | 17 | $274 | $16 |
| Trazodone | 33 | $268 | $8 |
| Omeprazole | 22 | $253 | $11 |
| Metformin | 44 | $250 | $6 |
| Glipizide | 38 | $247 | $6 |
| Bupropion Xl | 14 | $236 | $17 |
| Famotidine | 13 | $201 | $15 |
| Hydrochlorothiazide | 33 | $190 | $6 |
| Sertraline | 13 | $190 | $15 |
| Benazepril | 36 | $187 | $5 |
| Simvastatin | 36 | $181 | $5 |
| Fenofibrate | 12 | $176 | $15 |
| Alendronate | 21 | $169 | $8 |
| Atenolol | 14 | $149 | $11 |
| Primidone | 12 | $130 | $11 |
| Donepezil | 12 | $104 | $9 |
| Citalopram Hbr | 18 | $81 | $4 |
| Zolpidem | 11 | $79 | $7 |
| Allopurinol | 12 | $71 | $6 |
| Clopidogrel | 14 | $60 | $4 |
| Metformin Hcl Er | 11 | $52 | $5 |
2019: 43 drugs
| Lantus Solostar | 23 | $19,098 | $830 |
| Hydrocodone-Acetaminophen | 99 | $1,834 | $19 |
| Atorvastatin | 120 | $1,596 | $13 |
| Ventolin Hfa | 16 | $1,551 | $97 |
| Levothyroxine | 58 | $1,113 | $19 |
| Tamsulosin | 54 | $936 | $17 |
| Gabapentin | 27 | $866 | $32 |
| Ultra-Fine Short Pen Needle | 13 | $795 | $61 |
| Metoprolol | 32 | $769 | $24 |
| Fluticasone Propionate | 44 | $722 | $16 |
| Lisinopril | 93 | $617 | $7 |
| Albuterol Sulfate Hfa | 13 | $560 | $43 |
| Amlodipine Besylate | 68 | $501 | $7 |
| Azelastine | 17 | $482 | $28 |
| Losartan | 39 | $451 | $12 |
| Metformin | 68 | $431 | $6 |
| Ranitidine | 34 | $364 | $11 |
| Chlorthalidone | 15 | $278 | $19 |
| Omeprazole | 19 | $273 | $14 |
| Pravastatin | 13 | $272 | $21 |
| Naproxen | 26 | $265 | $10 |
| Simvastatin | 42 | $238 | $6 |
| Benazepril | 38 | $234 | $6 |
| Methadone | 17 | $224 | $13 |
| Fenofibrate | 12 | $223 | $19 |
| Donepezil | 19 | $197 | $10 |
| Baclofen | 12 | $193 | $16 |
| Alendronate | 23 | $174 | $8 |
| Pantoprazole | 17 | $159 | $9 |
| Hydrochlorothiazide | 21 | $148 | $7 |
| Allopurinol | 12 | $136 | $11 |
| Glipizide | 21 | $127 | $6 |
| Primidone | 11 | $125 | $11 |
| Sertraline | 14 | $116 | $8 |
| Triamcinolone Acetonide | 11 | $116 | $11 |
| Atenolol | 12 | $110 | $9 |
| Escitalopram | 12 | $104 | $9 |
| Clopidogrel | 16 | $98 | $6 |
| Hydromorphone | 17 | $98 | $6 |
| Metformin Hcl Er | 16 | $87 | $5 |
| Trazodone | 11 | $81 | $7 |
| Lorazepam | 11 | $65 | $6 |
| Diazepam | 13 | $47 | $4 |
2018: 35 drugs
| Lantus Solostar | 17 | $8,738 | $514 |
| Esomeprazole Magnesium | 16 | $2,345 | $147 |
| Hydrocodone-Acetaminophen | 60 | $1,175 | $20 |
| Proair Hfa | 13 | $991 | $76 |
| Gabapentin | 35 | $952 | $27 |
| Levothyroxine | 40 | $898 | $22 |
| Atorvastatin | 65 | $826 | $13 |
| Oxycodone-Acetaminophen | 17 | $533 | $31 |
| Chlorthalidone | 17 | $434 | $26 |
| Pravastatin | 13 | $371 | $29 |
| Metoprolol | 14 | $366 | $26 |
| Lisinopril | 66 | $352 | $5 |
| Methadone | 23 | $344 | $15 |
| Rosuvastatin | 14 | $342 | $24 |
| Metformin | 58 | $336 | $6 |
| Duloxetine | 15 | $319 | $21 |
| Fluticasone Propionate | 22 | $285 | $13 |
| Tamsulosin | 22 | $268 | $12 |
| Triamcinolone Acetonide | 11 | $247 | $22 |
| Naproxen | 24 | $222 | $9 |
| Amlodipine Besylate | 38 | $220 | $6 |
| Losartan | 24 | $210 | $9 |
| Terbinafine | 20 | $207 | $10 |
| Quetiapine | 19 | $197 | $10 |
| Allopurinol | 16 | $193 | $12 |
| Glipizide | 31 | $154 | $5 |
| Ranitidine | 15 | $152 | $10 |
| Benazepril | 13 | $129 | $10 |
| Promethazine | 11 | $111 | $10 |
| Clopidogrel | 11 | $77 | $7 |
| Diazepam | 15 | $50 | $3 |
| Hydrochlorothiazide | 11 | $47 | $4 |
| Simvastatin | 23 | $47 | $2 |
| Furosemide | 13 | $42 | $3 |
| Hydromorphone | 17 | $33 | $2 |
Professional record
- NPI
- 1033349998
- Licence
- CA A104098California A104098: Current · expires 2028-01-31
- Trained
- Medical College of Georgia School of Medicine, 2006
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 455 Oconnor Dr, Suite 200, San Jose, CA, 95128
- NPI first listed
- 2009-07-24
- NPI last updated
- 2009-07-24
This is when the NPI record was last certified, not a medical board exam.